Aayush Wellness (539528)

FairStock Score: 50/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Aayush Wellness as a Graham-style bargainer and Buffett-style quality seeker, but the numbers ask for caution. At ₹264.40 and a market cap of ₹1,287 Cr, the stock trades at 33.8 times earnings and an eye-watering 211.52 times book, with book value only ₹1.25. That leaves no margin of safety on asset value. The business does show high returns: ROE 73.89% and ROCE 51.02%, and recent sales growth of 73.66% is impressive. PEG of 0.46 suggests growth may be under-discounted if it persists. But I must reconcile that with a 5-year revenue CAGR of just 0.39%, which tells me the long-term record is not a compounding machine. Profit growth is -5.50% even as sales rise, and the latest quarter produced only ₹1 Cr net profit on ₹45 Cr sales. That is a thin cushion against a ₹1,287 Cr market cap. The Piotroski F-Score of 4/9 is below average, and the FairStock Score of 50/100 is mixed. The 52-week range—₹26.86 to ₹264.40—shows the price is at the top end, which often reflects momentum more than durable value. Dividend yield is only 0.08%. Debt/equity is N/A, so I cannot judge leverage. In a packaged foods business, I would want stable margins and consistent profit growth. Here, the quantitative clues point to a fast-growing but unproven enterprise with a very rich book valuation. I would not pay this price without seeing consistent profit growth, better F-score, and evidence that the recent sales surge is not a one-off. For an Indian retail investor, watch, don't chase.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer